Development of myelin oligodendrocyte glycoprotein autoreactive transgenic B lymphocytes:: Receptor editing in vivo after encounter of a self-antigen distinct from myelin oligodendrocyte glycoprotein

被引:29
作者
Litzenburger, T
Blüthmann, H
Morales, P
Pham-Dinh, D
Dautigny, A
Wekerle, H
Iglesias, A
机构
[1] Max Planck Inst Neurobiol, Dept Neuroimmunol, D-82152 Martinsried, Germany
[2] Roche AG, Basel, Switzerland
[3] Univ Autonoma Madrid, Ctr Biol Mol, E-28049 Madrid, Spain
[4] Univ Paris, UMR 7624, CNRS, F-75252 Paris, France
关键词
D O I
10.4049/jimmunol.165.9.5360
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We explored mechanisms involved in B cell self-tolerance against brain autoantigens in a double-transgenic mouse model carrying the Ig H-chain (introduced by gene replacement) and/or the L-chain K (conventional transgenic) of the mAb 8.18C5, specific for the myelin oligodendrocyte glycoprotein (MOG). Previously, we demonstrated that B cells expressing solely the MOG-specific Ig H-chain differentiate without tolerogenic censure. We show now that double-transgenic (TH kappa (mog)) B cells expressing transgenic Ig H- and L-chains are subjected to receptor editing. We show that in adult mice carrying both MOG-specific Ig H- and L-chains, the frequency of MOG-binding B cells is not higher than in mice expressings solely the transgenic Ig H-chain, In fact, in TH kappa (mog) double-transgenic mice, the transgenic kappa (mog) L-chain was commonly replaced by endogenous L-chains, i.e., by receptor editing. In rearrangement-deficient RAG-2(-) mice, differentiation of TH kappa (mog) B cells is blocked at an immature stage (defined by the B220(low)IgM(low)IgD(-) phenotype), reflecting interaction of the autoreactive B cells with a local self-determinant, The tolerogenic structure in the bone marrow is not classical MOG, because back-crossing TH kappa (mog) mice into a MOG-deficient genetic background does not lead to an increase in the proportion of MOG-binding B cells. We propose that an as yet undefined self-Ag distinct from MOG cross-reacts with the TH kappa (mog) B cell receptor and induces editing of the transgenic kappa (mog) L-chain in early immature B cells without affecting the pathogenic potential of the remaining MOG-specific B cells, This phenomenon represents a particular form of chain-specific split tolerance.
引用
收藏
页码:5360 / 5366
页数:7
相关论文
共 44 条
[1]   PURIFICATION AND PARTIAL STRUCTURAL AND FUNCTIONAL-CHARACTERIZATION OF MOUSE MYELIN OLIGODENDROCYTE GLYCOPROTEIN [J].
AMIGUET, P ;
GARDINIER, MV ;
ZANETTA, JP ;
MATTHIEU, JM .
JOURNAL OF NEUROCHEMISTRY, 1992, 58 (05) :1676-1682
[2]   Non-tolerant B cells cause autoimmunity in anti-CD8 IgG2a-transgenic mice [J].
Battegay, M ;
Fiedler, P ;
Kalinke, U ;
Brombacher, F ;
Zinkernagel, RM ;
Peter, HH ;
Kohler, G ;
Eibel, H .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (01) :250-258
[3]   Distinct signal thresholds for the unique antigen receptor-linked gene expression programs in mature and immature B cells [J].
Benschop, RJ ;
Melamed, D ;
Nemazee, D ;
Cambier, JC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (06) :749-756
[4]   IMMUNOGLOBULIN-M AND IMMUNOGLOBULIN-D ANTIGEN RECEPTORS ARE BOTH CAPABLE OF MEDIATING LYMPHOCYTE-B ACTIVATION, DELETION, OR ANERGY AFTER INTERACTION WITH SPECIFIC ANTIGEN [J].
BRINK, R ;
GOODNOW, CC ;
CROSBIE, J ;
ADAMS, E ;
ERIS, J ;
MASON, DY ;
HARTLEY, SB ;
BASTEN, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (04) :991-1005
[5]   DIFFERENTIAL ULTRASTRUCTURAL-LOCALIZATION OF MYELIN BASIC-PROTEIN, MYELIN OLIGODENDROGLIAL GLYCOPROTEIN, AND 2',3'-CYCLIC NUCLEOTIDE 3'-PHOSPHODIESTERASE IN THE CNS OF ADULT-RATS [J].
BRUNNER, C ;
LASSMANN, H ;
WAEHNELDT, TV ;
MATTHIEU, JM ;
LININGTON, C .
JOURNAL OF NEUROCHEMISTRY, 1989, 52 (01) :296-304
[6]   The development of B cells in the bone marrow is controlled by the balance between cell-autonomous mechanisms and signals from the microenvironment [J].
Carsetti, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (01) :5-8
[7]   Immunoglobulin heavy chain gene replacement: A mechanism of receptor editing [J].
Chen, C ;
Nagy, Z ;
Prak, EL ;
Weigert, M .
IMMUNITY, 1995, 3 (06) :747-755
[8]   Editing disease-associated autoantibodies [J].
Chen, C ;
Prak, EL ;
Weigert, M .
IMMUNITY, 1997, 6 (01) :97-105
[9]   THE SITE AND STAGE OF ANTI-DNA B-CELL DELETION [J].
CHEN, C ;
NAGY, Z ;
RADIC, MZ ;
HARDY, RR ;
HUSZAR, D ;
CAMPER, SA ;
WEIGERT, M .
NATURE, 1995, 373 (6511) :252-255
[10]  
CLAFLIN JL, 1988, J IMMUNOL, V141, P4012